Add
SRLS to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| SRLS > SEC Filings for SRLS > Form 8-K on 30-Sep-2009 | All Recent SEC Filings |
30-Sep-2009
Entry into a Material Definitive Agreement, Financial Statements and E
On each September 18, 2009 and September 23, 2009, SeraCare Life Sciences, Inc. (the "Company") extended its current contract with the National Institutes of Health ("NIH"), by entering into Amendments of Solicitation/Modification of Contract (collectively, the "Modifications"), by and between NIH and the Company. The following summary of the Modifications is qualified in its entirety by reference to the text of the Press Release issued on September 29, 2009 by the Company, a copy which is furnished as Exhibit 10.1 to this Current Report on Form 8-K and incorported herein by reference.
Under the Modifications, the Company was awarded extensions on the existing contract with the NIH to continue to support the National Heart, Lung and Blood Institute National Repository ("NHLBI") by supporting the growth of the repository and quality control of the historic AIDS and AIDS related studies in the NHLBI collection in preparation for anticipated broader use. Under the Modifications, the total 12-year contract value increased from $5.2 milion to $19.0 million. The $5.2 million expansion increases the remaining value of the contract over the next two years to $6.3 million.
(D) Exhibits. The following exhibit is filed as part of this report:
10.1 Press Release by SeraCare Life Sciences, Inc. dated September 29, 2009.
|
|